Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hawkeye Bio
company
About
Hawkeye Bio is a medical technology company focused on the early detection of cancer, infectious disease and autoimmune disease.
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Hawkeye Bio is developing patented nanoscale biosensors (NBS) for disease detection. The company's lead clinical program in oncology is focused on the deployment of nanobiosensors to non-invasively detect early stage cancer. Identifying cancer reliably, safely, and affordably at the earliest stage is critical for successful treatment and survival. The NBS are also being evaluated to monitor patients post-treatment to identify cases of minimal residual disease and intercept recurrence. The NBS platform is also being clinically evaluated for applications in infectious and autoimmune disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Hawkeye Bio has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2020 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2020 | Convertable Note | — | 1 | — | — | Detail |
| Jan 2, 2018 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Hawkeye Bio is funded by 1 investors.
NJF Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
NJF Capital
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
